Steinhubl, S.: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Aspirin and Clopidogrel Resistance: Does it Matter in Clinical Practice?

Brian R. Dulin, Steven R. Steinhubl

Journal:

ACC Current Journal Review

Year:

2005

Language:

english

File:

PDF, 113 KB

english, 2005

52

Comparison of long-term usefulness of clopidogrel therapy after the first percutaneous coronary intervention or coronary artery bypass grafting versus that after the second or repeat intervention

Jacqueline Saw, Eric J. Topol, Steven R. Steinhubl, Danielle Brennan, Peter B. Berger, David J. Moliterno

Journal:

The American Journal of Cardiology

Year:

2004

Language:

english

File:

PDF, 85 KB

english, 2004

53

Analysis of Risk of Bleeding Complications After Different Doses of Aspirin in 192,036 Patients Enrolled in 31 Randomized Controlled Trials

Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Jeffrey S. Baggish, Deepak L. Bhatt, Eric J. Topol

Journal:

The American Journal of Cardiology

Year:

2005

Language:

english

File:

PDF, 120 KB

english, 2005

54

Onset and Offset of Platelet Inhibition After High-Dose Clopidogrel Loading and Standard Daily Therapy Measured by a Point-of-Care Assay in Healthy Volunteers

Matthew J. Price, Jacqueline L. Coleman, Steven R. Steinhubl, Garrett B. Wong, Christopher P. Cannon, Paul S. Teirstein

Journal:

The American Journal of Cardiology

Year:

2006

Language:

english

File:

PDF, 294 KB

english, 2006

55

Why Have Antioxidants Failed in Clinical Trials?

Steven R. Steinhubl

Journal:

The American Journal of Cardiology

Year:

2008

Language:

english

File:

PDF, 311 KB

english, 2008

56

Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?

Tobias Geisler, Meinrad Gawaz, Steven R. Steinhubl, Deepak L. Bhatt, Robert F. Storey, Marcus Flather

Journal:

Pharmacology & Therapeutics

Year:

2010

Language:

english

File:

PDF, 651 KB

english, 2010

57

Corrigendum to “Current strategies in antiplatelet therapy — Does identification of risk and adjustment of therapy contribute to more effective, personalized medicine in cardiovascular disease?” [Pharmacol. Ther. 127(2) (2010) 95–107]

Tobias Geisler, Meinrad Gawaz, Steven R. Steinhubl, Deepak L. Bhatt, Robert F. Storey, Marcus Flather

Journal:

Pharmacology & Therapeutics

Year:

2010

Language:

english

File:

PDF, 91 KB

english, 2010

58

Relation of platelet inactivation with intravenous glycoprotein IIb/IIIa antagonists to major bleeding (from the GOLD study)

Michael R Tamberella, Deepak L Bhatt, Derek P Chew, Dean J Kereiakes, Eric J Topol, Steven R Steinhubl

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 75 KB

english, 2002

59

Usefulness of the response to sublingual nitroglycerin as a predictor of ischemic chest pain in the emergency department

Eric A Shry, Jennifer Dacus, Eric Van De Graaff, Michael Hjelkrem, Karl C Stajduhar, Steven R Steinhubl

Journal:

The American Journal of Cardiology

Year:

2002

Language:

english

File:

PDF, 57 KB

english, 2002

60

Abciximab (ReoPro) removal during cardiopulmonary bypass with a hemoconcentrator

Steven R. Steinhubl, Scott A. Moore, A.Michael Lincoff

Journal:

The Journal of Thoracic and Cardiovascular Surgery

Year:

2000

Language:

english

File:

PDF, 16 KB

english, 2000

61

Ticlopidine pretreatment before coronary stenting is associated with sustsained decrease of adverse cardiac events: data from the evaluation of platelet IIb/IIIa inhibitor for stenting (EPISTENT trial)

R Steinhubl, S.G Ellis, K Wolski K

Journal:

ACC Current Journal Review

Year:

2001

Language:

english

File:

PDF, 37 KB

english, 2001

62

Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study

S.R Steinhubl, D.J Talley, B.A Braden

Journal:

ACC Current Journal Review

Year:

2001

Language:

english

File:

PDF, 39 KB

english, 2001

63

Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention

S.R. Steinhubl, P.B. Berger, J.T. Mann

Journal:

ACC Current Journal Review

Year:

2003

Language:

english

File:

PDF, 42 KB

english, 2003

64

Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation

James L Orford, Panayotis Fasseas, Steven Melby, Kelli Burger, Steven R Steinhubl, David R Holmes, Peter B Berger

Journal:

American Heart Journal

Year:

2004

Language:

english

File:

PDF, 93 KB

english, 2004

65

Heparin-induced thrombocytopenia and cardiovascular diseases

Pranab Das, Khaled Ziada, Steven R. Steinhubl, David J. Moliterno, Hussam Hamdalla, Joseph Jozic, Debabrata Mukherjee

Journal:

American Heart Journal

Year:

2006

Language:

english

File:

PDF, 226 KB

english, 2006

66

Clopidogrel-statin interaction: A mountain or a mole hill?

Steven R. Steinhubl, W. Scott Akers

Journal:

American Heart Journal

Year:

2006

Language:

english

File:

PDF, 77 KB

english, 2006

67

Risk stratification for patients undergoing nonurgent percutaneous coronary intervention using N-terminal pro–B-type natriuretic peptide: A Clopidogrel for the Reduction of Events During Observation (CREDO) substudy

W.H. Wilson Tang, Steven R. Steinhubl, Frederick Van Lente, Danielle Brennan, Ellen McErlean, Anjli Maroo, Gary S. Francis, Eric J. Topol

Journal:

American Heart Journal

Year:

2007

Language:

english

File:

PDF, 326 KB

english, 2007

68

Peroxisome proliferator–activated receptor γ agonists for the Prevention of Adverse events following percutaneous coronary Revascularization—results of the PPAR Study

Deepak L. Bhatt, Derek P. Chew, Cindy Grines, Debabrata Mukherjee, Massoud Leesar, Ian C. Gilchrist, John C. Corbelli, James C. Blankenship, Avichai Eres, Steven Steinhubl, Walter A. Tan, Jon R. Resar

Journal:

American Heart Journal

Year:

2007

Language:

english

File:

PDF, 118 KB

english, 2007

69

Variation in the definitions of bleeding in clinical trials of patients with acute coronary syndromes and undergoing percutaneous coronary interventions and its impact on the apparent safety of antithrombotic drugs

Steven R. Steinhubl, Adnan Kastrati, Peter B. Berger

Journal:

American Heart Journal

Year:

2007

Language:

english

File:

PDF, 308 KB

english, 2007

70

Atrial fibrillation in the setting of acute myocardial infarction —irregularly irregular treatment

Charles L. Campbell, Steven R. Steinhubl

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 70 KB

english, 2008

71

Efficacy and safety of clopidogrel pretreatment before percutaneous coronary intervention with and without glycoprotein IIb/IIIa inhibitor use

Marc S. Sabatine, Hussam N. Hamdalla, Shamir R. Mehta, Keith A.A. Fox, Eric J. Topol, Steven R. Steinhubl, Christopher P. Cannon

Journal:

American Heart Journal

Year:

2008

Language:

english

File:

PDF, 400 KB

english, 2008

72

Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention: Insights from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial

Herbert D. Aronow, Steven R. Steinhubl, Danielle M. Brennan, Peter B. Berger, Eric J. Topol

Journal:

American Heart Journal

Year:

2009

Language:

english

File:

PDF, 181 KB

english, 2009

73

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

Harvey D. White, Philip E. Aylward, Richard Gallo, Christoph Bode, Gabriel Steg, Steven R. Steinhubl, Gilles Montalescot

Journal:

American Heart Journal

Year:

2010

Language:

english

File:

PDF, 270 KB

english, 2010

74

Clopidogrel pretreatment in ST-elevation myocardial infarction patients transferred for percutaneous coronary Intervention

David M. Larson, Sue Duval, Scott S. Sharkey, Christopher Solie, Craig Tschautscher, Daniel L. Lips, M. Nicholas Burke, Steven Steinhubl, Timothy D. Henry

Journal:

American Heart Journal

Year:

2010

Language:

english

File:

PDF, 219 KB

english, 2010

75

Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: Results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial

Adriano Caixeta, George D. Dangas, Roxana Mehran, Frederick Feit, Eugenia Nikolsky, Alexandra J. Lansky, Jiro Aoki, Jeffrey W. Moses, Steven R. Steinhubl, Harvey D. White, E. Magnus Ohman, Steven V. M

Journal:

American Heart Journal

Year:

2011

Language:

english

File:

PDF, 541 KB

english, 2011

76

Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial

Jeffrey S. Berger, Deepak L. Bhatt, P. Gabriel Steg, Steven R. Steinhubl, Gilles Montalescot, Mingyuan Shao, Werner Hacke, Keith A. Fox, Peter B. Berger, Eric J. Topol, A. Michael Lincoff

Journal:

American Heart Journal

Year:

2011

Language:

english

File:

PDF, 327 KB

english, 2011

77

Commentary

Steven R Steinhubl

Journal:

Evidence-based Cardiovascular Medicine

Year:

2005

Language:

english

File:

PDF, 97 KB

english, 2005

78

Development and validation of a bleeding risk model for patients undergoing elective percutaneous coronary intervention

Gilles Montalescot, Genevieve Salette, Gabriel Steg, Marc Cohen, Harvey D. White, Richard Gallo, Steven R. Steinhubl

Journal:

International Journal of Cardiology

Year:

2011

Language:

english

File:

PDF, 194 KB

english, 2011

79

Platelet activation and its patient-specific consequences

Susan S. Smyth, Dougald M. Monroe III, Waldemar E. Wysokinski, Robert D. McBane II, Sidney W. Whiteheart, Richard C. Becker, Steven R. Steinhubl

Journal:

Thrombosis Research

Year:

2008

Language:

english

File:

PDF, 228 KB

english, 2008

80

Transitioning patients from cangrelor to clopidogrel: Pharmacodynamic evidence of a competitive effect

Steven R. Steinhubl, Jennifer J. Oh, Julie H. Oestreich, Suellen Ferraris, Richard Charnigo, Wendell S. Akers

Journal:

Thrombosis Research

Year:

2008

Language:

english

File:

PDF, 300 KB

english, 2008

81

What is the role for improved long-term antiplatelet therapy after percutaneous coronary intervention?

Steven Steinhubl, Peter Berger

Journal:

American Heart Journal

Year:

2003

Language:

english

File:

PDF, 347 KB

english, 2003

82

Percutaneous coronary interventions in patients with renal insufficiency: a high-risk, under-studied cohort

Steven R. Steinhubl

Journal:

American Heart Journal

Year:

2003

Language:

english

File:

PDF, 55 KB

english, 2003

83

Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial

Victor L Serebruany, Alex I Malinin, Scott D Jerome, David R Lowry, Athol W Morgan, David C Sane, Jean-François Tanguay, Steven R Steinhubl, Christopher M O'Connor

Journal:

American Heart Journal

Year:

2003

Language:

english

File:

PDF, 136 KB

english, 2003

84

Uniform platelet activation exists before coronary stent implantation despite aspirin therapy

Victor L. Serebruany, Charles C. Cummings, Alex I. Malinin, Steven R. Steinhubl, Paul A. Gurbel

Journal:

American Heart Journal

Year:

2001

Language:

english

File:

PDF, 82 KB

english, 2001

85

The ultegra rapid platelet-function assay: Comparison to standard platelet function assays in patients undergoing percutaneous coronary intervention with abciximab therapy

Guy L. Wheeler, Gregory A. Braden, Steven R. Steinhubl, Dean J. Kereiakes, Kandice Kottke-Marchant, Alan D. Michelson, Mark I. Furman, Michele N. Mueller, David J. Moliterno, David C. Sane

Journal:

American Heart Journal

Year:

2002

Language:

english

File:

PDF, 486 KB

english, 2002

86

Clopidogrel’s role in the management of atherosclerotic disease: a focus on acute coronary syndromes

Steinhubl, Steven R, Rodgers, Jo E

Journal:

Expert Review of Cardiovascular Therapy

Year:

2003

Language:

english

File:

PDF, 201 KB

english, 2003

87

Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease

Steinhubl, S. R., Badimon, J. J., Bhatt, D. L., Herbert, J.-M., Luscher, T. F.

Journal:

Vascular Medicine

Year:

2007

Language:

english

File:

PDF, 290 KB

english, 2007

88

Association between inflammatory biomarkers and platelet aggregation in patients under chronic clopidogrel treatment

Bernlochner, I., Steinhubl, S. R., Braun, S., Morath, T., Jaitner, J., Stegherr, J., Mehilli, J., von Beckerath, N., Schömig, A., Kastrati, A., Sibbing, D.

Journal:

Thrombosis and Haemostasis

Year:

2010

Language:

english

File:

PDF, 246 KB

english, 2010

89

Capturing the Potential for Breakout Performance

Steinhubl, Andrew

Journal:

Journal of Petroleum Technology

Year:

1996

Language:

english

File:

PDF, 161 KB

english, 1996

90

Stenting for acute myocardial infarction

Steven R Steinhubl, Eric J Topol

Journal:

Year:

1997

Language:

english

File:

PDF, 52 KB

english, 1997

91

POTENTIAL IMPACT OF PREDICTIVE MODELS FOR EARLY DETECTION OF HEART FAILURE ON THE INITIATION OF EVIDENCE-BASED THERAPIES

Rajakrishnan VHavakrishnan, Steven R. Steinhubl, Jimeng Sun, Roy J. Byrd, Zahra Daar, Jason Thompson, Shahram Ebadollahi, Walter F. Stewart

Journal:

Journal of the American College of Cardiology

Year:

2012

Language:

english

File:

PDF, 91 KB

english, 2012

92

The duration of pretreatment with ticlopidine prior to stenting is associated with the risk of procedure-related non–Q-wave myocardial infarctions

Steven R Steinhubl, Michael S Lauer, Debabrata P Mukherjee, David J Moliterno, A. Michael Lincoff, Stephen G Ellis, Eric J Topol

Journal:

Journal of the American College of Cardiology

Year:

1998

Language:

english

File:

PDF, 66 KB

english, 1998

93

Pretreatment with ticlopidine reduces non-Q-wave myocardial infarctions following intracoronary stenting

S.R. Steinhubl, M.S. Lauer, D.P. Mukerjee, D.J. Molitemo, S.G. Ellis, E.J. Topol

Journal:

Journal of the American College of Cardiology

Year:

1998

Language:

english

File:

PDF, 103 KB

english, 1998

94

PCV43 CLINICAL AND ECONOMIC IMPACT OF BIVALIRUDIN ON BLEEDING EVENTS IN HIGH RISK UNSTABLE ANGINA (UA)/NON-ST-ELEVATION MYOCARDIAL INFARCTION (NSTEMI) PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI) IN FRANCE

N Olchanski, K Slawsky, P Cyr, M Schwenkglenks, S Steinhubl

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 80 KB

english, 2010

95

PCV46 A FRENCH HOSPITAL BUDGET IMPACT MODEL COMPARING ANTICOAGULATION STRATEGIES IN PRIMARY PERCUTANEOUS CORONARY INTERVENTION

N Olchanski, K Slawsky, P Cyr, M Schwenkglenks, S Steinhubl

Journal:

Value in Health

Year:

2010

Language:

english

File:

PDF, 78 KB

english, 2010

96

Clinical outcomes according to permanent discontinuation of clopidogrel or placebo in the CHARISMA trial

Jean-Philippe Collet, Gilles Montalescot, Philippe Gabriel Steg, Steven R. Steinhubl, Keith A.A. Fox, Ting Fei Hu, S. Claiborne Johnston, Christian W. Hamm, Deepak L. Bhatt, Eric J. Topol

Journal:

Archives of Cardiovascular Diseases

Year:

2009

File:

PDF, 829 KB

2009

97

Risk stratification for patients undergoing elective percutaneous coronary intervention using plasma N-terminal pro-B-type natriuretic peptide assay: a clopidogrel for reduction of events during observation (CREDO) sub-study

W.H.Wilson Tang, Stephen Steinhubl, Frederick Van Lente, Danielle Brennan, Ellen S. McErlean, Stephen P. Marso, Gary S. Francis, Eric J. Topol

Journal:

Journal of Cardiac Failure

Year:

2004

Language:

english

File:

PDF, 57 KB

english, 2004

98

Influence of treatment duration with a 600-mg dose of clopidogrel before percutaneous coronary revascularization

David E. Kandzari, Peter B. Berger, Adnan Kastrati, Steven R. Steinhubl, Julinda Mehilli, Franz Dotzer, Jurriën M. ten Berg, Franz-Josef Neumann, Hildegard Bollwein, Josef Dirschinger, Albert Schömig

Journal:

Journal of the American College of Cardiology

Year:

2004

Language:

english

File:

PDF, 92 KB

english, 2004

99

Variability in platelet responsiveness to clopidogrel among 544 individuals

Victor L. Serebruany, Steven R. Steinhubl, Peter B. Berger, Alex I. Malinin, Deepak L. Bhatt, Eric J. Topol

Journal:

Journal of the American College of Cardiology

Year:

2005

Language:

english

File:

PDF, 246 KB

english, 2005

100

Long-Term Cost Effectiveness of Early and Sustained Dual Oral Antiplatelet Therapy With Clopidogrel Given for Up to One Year After Percutaneous Coronary Intervention: Results From the Clopidogrel for the Reduction of Events During Observation (CREDO) Trial

Sean C. Beinart, Paul Kolm, Emir Veledar, Zefeng Zhang, Elizabeth M. Mahoney, Olivier Bouin, Sylvie Gabriel, Joseph Jackson, Roland Chen, Jaime Caro, Steven Steinhubl, Eric Topol, William S. Weintraub

Journal:

Journal of the American College of Cardiology

Year:

2005

Language:

english

File:

PDF, 206 KB

english, 2005